IDERA PHARMACEUTICALS, INC. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jan 3, 2008
Insider Transaction Report
Form 4
WYNGAARDEN JAMES B
Director
Transactions
- Award
Stock Options
2008-01-02+16,000→ 16,000 totalExercise: $13.28Exp: 2018-01-02→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The options will vest quarterly over a three year period, beginning 4/2/2008.